Ardsley Advisory Partners’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FLAM
PCM
Ardsley Advisory Partners's ATRC Position: Q1 2019 in Review
Ardsley Advisory Partners sold out of AtriCure (ATRC) in Q1 2019, closing a stake of 15,000 shares — an estimated $459K sold.
Ardsley Advisory Partners first reported a position in ATRC in Q2 2013 and held it in 16 quarters. The position peaked at $739K in Q4 2014. 160 funds tracked by Wall St. Rank hold ATRC as of Q1 2019.
- Ardsley Advisory Partners reported no remaining AtriCure position as of Q1 2019 after selling out during the quarter.
- Ardsley Advisory Partners sold 15,000 AtriCure shares in Q1 2019, an estimated $459K.
- Ardsley Advisory Partners first reported a position in AtriCure in Q2 2013 and held it in 16 quarters.
- Ardsley Advisory Partners's AtriCure position peaked at $739K in Q4 2014.
- 160 funds tracked by Wall St. Rank held AtriCure as of Q1 2019.
Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.